Patients with moderate to severe asthma saw increases in FEV1 within 24 hours after taking a loading dose of rademikibart, ...

Remote study conducted at Rutgers and elsewhere finds albuterol-budesonide mix cuts risk for mild cases and may let patients ...

AstraZeneca presented data from the phase 3 BATURA study which showed that use of Airsupra in those with mild asthma reduced ...

In severe asthma, most patients who seek acute care do so due to symptom severity and need for rapid care when rescue ...

Tezepelumab, a monoclonal antibody targeting TSLP approved for add-on severe asthma treatment in 2021, had been associated ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

JAMESTOWN, N.D. (JRMC) -Jamestown Regional Medical Center (JRMC) is now able to perform fractional exhaled nitric oxide (FeNO ...

The study evaluated 807 adults who initiated an anti–IL–5 therapy (79% mepolizumab, 21% benralizumab) between 2017 and 2020.

All participants will initially undergo a run-in period on standardised medium-dose ICS/LABA to confirm persistent lack of ...